Stemina Biomarker Discovery is Biotechnology in United States that focus on developer business. Founded in 2006. They cover business area such as developer, molecular biomarker, diagnosis, neurological disorder, autism spectrum disorder, drug screening service, human embryonic stem cell, chemical, consumer product, cosmetic, their potential effect, physician, insight, human response, physiologically relevant tissue.
2006
( 18 years old in 2024 )
Developer
-
504 South Rosa Road
Suite 150
Madison, WI 53719
United States
Private
developermolecular biomarkerdiagnosisneurological disorderautism spectrum disorderdrug screening servicehuman embryonic stem cellchemicalconsumer productcosmetictheir potential effectphysicianinsighthuman responsephysiologically relevant tissue
* We use standard office opening hours in near Stemina Biomarker Discovery's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stemina Biomarker Discovery is Biotechnology business from United States that founded in 2006 (18 years old in 2024), Stemina Biomarker Discovery business is focusing on Developer.
Stemina Biomarker Discovery headquarter office and corporate office address is located in 504 South Rosa Road Suite 150 Madison, WI 53719 United States.
Stemina Biomarker Discovery was founded in United States.
In 2024, Stemina Biomarker Discovery is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stemina Biomarker Discovery, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
